Canada Pharmaceuticals & Healthcare Report Q3 2012 - New Market Research Report
BMI View: According to the Canadian Institute for Health Information, the growth of spending on prescription drugs in Canada slowed to its lowest level since 1996 in 2011, when it came in at just 4% year-on-year (y-o-y). This slowdown was attributed to the expiration of certain blockbuster drugs' patents, which will continue to place downward pressure on the growth of the overall pharmaceutical market in the country. Nevertheless, epidemiological demands of an ageing population will serve to counterbalance some of...
View full press release